Trial in Progress: A Phase 1b Single-Arm, Open-Label Study of Emavusertib (CA-4948) in Combination with Azacitidine and Venetoclax in Acute Myeloid Leukemia Patients in Complete Response with Measurable Residual Disease

Venclexta (venetoclax) - Roche, AbbVie

azacitidine - Generic mfg.

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Adolfo De La Fuente Burguera; Claudio Cerchione; Sebastian Scholl; Jan Moritz Middeke; Gaurav S Choudhary; Reinhard von Roemeling; Uwe Platzbecker

Dec 3, 2023